AVLN compared with MPLT: revenue, margins and what each company keeps, and the suppliers and customers both name

AVLNAvalyn Pharma Inc.

Mkt capRevenueRevenue

MPLTMapLight Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AVLNAvalyn Pharma Inc.

MPLTMapLight Therapeutics, Inc.

Price

Mkt cap

Revenue

Supply-chain overlap

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

direct ties · both sidesSources ›

direct ties · both sides

Only AVLN 0

None

Shared 0

No disclosed counterparties: AVLN.

Only MPLT 3

—NeuroSolisunlistedsupplier

—Vanderbilt Universityunlistedsupplier

—Michael J. Fox Foundationunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AVLNAvalyn Pharma Inc.

25.71▲+0.31%· post 25.73· delayed

Mkt cap$759.9M

MPLTMapLight Therapeutics, Inc.

6.82▼−10.04%· post 6.79· delayed

After hoursNov 2 '26delayed

Mkt cap$344.4M

Compare

After hoursNov 2 '26delayed

AVLNAvalyn Pharma Inc.

MPLTMapLight Therapeutics, Inc.

25.71▲+0.31%post 25.73delayed

Price

6.82▼−10.04%post 6.79delayed

$759.9M

Mkt cap

$344.4M

AVLN25.71▲+0.31%vsMPLT6.82▼−10.04%After hoursNov 2 '26delayed